And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Topic: Cosmetic

News | January 22, 2020

Final Data Support Efficacy of Revian Red System for Hair Growth

Final data from a randomized, double-blind study of the Revian Red hair growth system demonstrated the ability of the system to successfully stop hair loss and subsequently grow new hair. Findings were presented at the 2020 Winter...

Read More
DermWireTV: Meet Crown Aesthetics, Revance to Market Teoxane Fillers, Almirall Collaborates thumbnail
Play Button

DermWireTV: Meet Crown Aesthetics, Revance to Market Teoxane Fillers, Almirall Collaborates

Series: DermWire TV | January 21, 2020

On the heels of recent acquisitions, Crown Laboratories is reorganizing and rebranding as three divisions: Crown Aesthetics, Crown Beauty, and Crown Therapeutics. Revance gains immediate and exclusive rights to commercialize Teoxane’s RHA 2, RHA 3, and RHA 4 products, which include lidocaine. A fourth product, RHA 1, is currently in clinical trials in the US with FDA approval anticipated in 2021. Almirall seeks to enhance its early-stage research portfolio and expand its medical dermatology pipeline with three new collaborations.

Watch Video
Features | January 2020

Free Cartilage-Mucosa Composite Graft for Closure of Nasal Septal Perforations

The majority of NSP repairs are not performed by community dermatologists and cosmetic surgeons, but a simple technique could change that.
Michael A. Alexiou, MD

Nasal septal perforations (NSP) result from a dehiscence of the juxtaposed mucosal and cartilaginous layers of the septum. For patients, they produce symptoms of crusting, bleeding, and nasal whistling during inspiration. Common etiologies...

Read Article

News | January 14, 2020

South Beach Symposium Poised for 18th Miami Conference

The 18th Annual South Beach Symposium takes place in Miami Beach next month. Organizers say the annual conference boasts an extensive agenda, with in-depth pre-conference offerings, and sessions topics covering the latest and most...

Read More

News | January 10, 2020

Revance Acquires Exclusive US Distribution Rights to Teoxane SA Fillers

Revance Therapeutics, Inc. is the exclusive commercialization partner of Teoxane SA in the US. With a new distribution agreement just announced, Revance gains immediate and exclusive rights to commercialize Teoxane’s Resilient...

Read More

Advertisement

The Latest in Cosmetic

Advertisement

View more